Isoflurane is a halogenated ether, first introduced in the 1980s, which rapidly gained popularity due to its favorable properties, including low blood-gas solubility and minimal cardiovascular effects. These qualities allow for rapid induction and recovery from anesthesia. Its efficiency, however, comes at a price, which varies significantly across different markets and healthcare settings.